Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Frick M, Fischer J, Helbling A, Ruëff F, Wieczorek D, Ollert M, Pfützner W, Müller S, Huss-Marp J, Dorn B, Biedermann T, Lidholm J, Ruecker G, Bantleon F, Miehe M, Spillner E, Jakob T.
Frick M, et al. Among authors: jakob t.
J Allergy Clin Immunol. 2016 Dec;138(6):1663-1671.e9. doi: 10.1016/j.jaci.2016.04.024. Epub 2016 May 24.
J Allergy Clin Immunol. 2016.
PMID: 27372568
Free article.